Board / shareholder meeting outcomeFiled on BSE ·

Natco Pharma Limited announces results of 43rd AGM held on 30 September 2026

Natco Pharma · Pharmaceuticals & Biotechnology

What the filing says

  • All resolutions including adoption of audited financials, dividend confirmation, director re-appointment, cost auditor remuneration ratification, and fund raising approval (up to ₹2,000 crore) passed with requisite majority.
  • Remote e-voting was held from 27 to 29 September 2026; e-voting during AGM on 30 September 2026, scrutinized by CS Kiran Kumar Bodla.
  • Total shareholders on cut-off date (25 September 2026) were 4,22,879; promoter and public votes overwhelmingly in favor across all items.

Original filing

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies

Electrical Equipment

Revenue: Rank 1Margin: Rank 1

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Natco Pharma

Other board / shareholder meeting outcome filings this fortnight

All board / shareholder meeting outcome filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.